Tissue engineering is the combination of biology medicine and engineering to create products that would improve or replace biological functions or organs. More than a decade ago, the industry introduced the first FDA approved tissue-engineering product, which was a skin substitute product. These products provide natural regeneration of tissues or cells, and hence are highly effective. The medical biotechnology industry was estimated to be $160 billion in 2012.The major drivers in this industry are chronic wound and orthopedic application segment. The requirement of tissue engineered bone substitutes is increasing with a rate of 22.5% per year. The complexity in growing these tissue cultures and the cost involved are limiting the growth of this market. The increasing use of these products in various medical fields such as dental, cardiac, etc., would provide growth opportunities for this industry.
Global tissue engineering and regeneration technology market analysis
The global market for these products is classified based on technology used in stem cell technology, cell culture technology and immunoisolation technology. Of all these technologies, presently cell culture technology is most commonly used. Stem cells are also being employed in the production of these products.
Global tissue engineering and regeneration application market analysis
This market is classified based on its application into Organ Regeneration, cardiovascular, dental, dermal, orthopedic dermatology, oncology, neurology and urology. Of all these, maximum revenue is generated from orthopedic and dermal applications.
Global tissue engineering and regeneration geography market analysis
This market is classified based on its geography into North America, Europe, Asia-Pacific and rest of the world (RoW). North American market is the highest revenue generating region for this vaccine.
The major players in this market are,Advanced Cell Technology CryoLife, LifeCell Kinetic Concepts, Cook Biotech, StemCells, Inc., Sanofi, , BioMemetic Therapeutics, Cytori Therapeutics and Aastrom BioScience. The companies are focusing mainly on getting approval and patents for their products.
High level Analysis
The report analyses global tissue engineering and regeneration market with the help of Porter’s five forces model. Porter’s model helps in analyzing the market players, new entrants in the market and the strategies adopted by them. The bargaining power of customers and suppliers are analyzed based on market players.. Market dynamics is analyzed would enable stakeholders to formulate strategies.
- Estimations are made by considering current market trends, and future potential investment for analysis period 2014-2020
- The research analysis explains the current market structure and market projections for upcoming years to provide a fair idea of market to the stakeholders
- The study highlights the market drivers, limitations and opportunities of this market
- Porter’s five force model discusses the market player’s business plans which would help in developing new market strategies
- The analysis and forecast made helps in understanding the future scope of the technology, which would benefit the stakeholders
KEY MARKET SEGMENTS
The global tissue engineering and regeneration market is categorized into technology, material, application and geography.
Market by Technology
- Stem Cell Technology
- Cell Culture Technology
- Immunoisolation Technology
Market by Applications
- Organ Regeneration
- Orthopedic Applications
Market by Geography
- North America